期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 28, 期 3, 页码 310-331出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v28.i3.310
关键词
Non-alcoholic fatty liver disease; Hepatocellular carcinoma; Epidemiology; Risk factors; Surveillance; Risk stratification
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide, mainly attributed to the increasing prevalence of obesity and type 2 diabetes mellitus. NAFLD can progress to non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). This review focuses on the epidemiology, pathogenesis, risk factors, and prognosis of NAFLD-HCC patients. It highlights the underdiagnosis of NAFLD as an underlying liver disease for HCC and emphasizes the importance of prevention and appropriate surveillance policies for these patients.
Non-alcoholic fatty liver disease (NAFLD) has emerged as the most common liver disorder worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus. Although it is considered a benign disease, NAFLD can progress to non-alcoholic steatohepatitis, liver cirrhosis and hepatocellular carcinoma (HCC). Most data regarding the epidemiology of NAFLD-related HCC are derived from cohort and population studies and show that its incidence is increasing as well as it is likely to emerge as the leading indication for liver transplantation, especially in the Western World. Although cirrhosis constitutes the main risk factor for HCC development, in patients with NAFLD, HCC can arise in the absence of cirrhosis, indicating specific carcinogenic molecular pathways. Since NAFLD as an underlying liver disease for HCC is often underdiagnosed due to lack of sufficient surveillance in this population, NAFLD-HCC patients are at advanced HCC stage at the time of diagnosis making the management of those patients clinically challenging and affecting their prognostic outcomes. In this current review, we summarize the latest literature on the epidemiology, other than liver cirrhosis-pathogenesis, risk factors and prognosis of NAFLD-HCC patients. Finally, we emphasize the prevention of the development of NAFLD-associated HCC and we provide some insight into the open questions and issues regarding the appropriate surveillance policies for those patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据